Showing results (1-10 of 82) with videos related to
Sort By:
Pageof 9
Clinical Calcium|March 19, 2005
[Intervention therapy for secondary hyperparathyroidism]Takatoshi KakutaClinical Calcium|May 2, 2007
[Guideline for the management of chronic kidney disease-related mineral and bone disorders (CKD-MBD)]Takatoshi KakutaClinical Calcium|December 4, 2004
[PEIT is the part of strategy for severe hyperparathyroidism in patients requiring hemodialysis]Katsuya Uemura, Takatoshi KakutaClinical Calcium|November 27, 2014
[New Developments in CKD-MBD. Cell Biology of parathyroid in CKD]Takatoshi Kakuta, Kaichiro SawadaClinical Calcium|June 30, 2010
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Parathyroid interventions: final one piece in the management of uremic SHPT patients]Katsuya Uemura, Takatoshi KakutaClinical Calcium|March 19, 2005
[Vitamin D and its analogs in the treatment of hypoparathyroidism]Takatoshi Kakuta, Futoshi TadakiClinical Calcium|May 1, 2015
[Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)]Momoyo Omata, Masafumi Fukagawa, Takatoshi KakutaClinical Calcium|March 7, 2007
[Relationship between sevelamer HCl and vascular calcification]Katsuya Uemura, Takatoshi Kakuta, Akira SaitoClinical and Experimental Nephrology|January 4, 2017
Management of secondary hyperparathyroidism: how and why?Hirotaka Komaba, Takatoshi Kakuta, Masafumi FukagawaTherapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 22, 2018
Critical Governance Issue of Parathyroid Hormone Assays and its Selection in the Management of Chronic Kidney Disease Mineral and Bone DisordersTakatoshi Kakuta, Mari Ishida, Masafumi FukagawaPageof 9